By Maggie Fick, Mrinalika Roy and Sabrina ValleSAN FRANCISCO, Jan 12 (Reuters) - Oral weight-loss drugs could account for a ...
Novo Nordisk anticipates oral weight-loss drugs will capture one-third or more of the GLP-1 market by 2030, driven by ...
A recent study led by Associate Professor Anne Loft, Associate Professor Jesper Grud Skat Madsen, and Professor Susanna ...
One humiliating moment at a party changed her life. In just a year, this British woman dropped from 99 kg to around 60 kg, ...
Those with a high BMI may face heightened risks of the various health complications linked with excess weight or obesity, ...
Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead increase the risk of chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback